ARCHIVES

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 04 | January 26, 2001

Download PDF Visit The Full Archive

Related Articles

NCI To Broaden Support, Especially For Staff, Through Core Grants to Comprehensive Centers

November 21, 1975

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

Benefits of Mammography Outweigh Harms In Women with Increased Risk, Starting at Age 40

April 27, 2012

NCI Staff Will Recommend That Comprehensive Recognition Be Withdrawn From Colorado Center

October 31, 1980

NEJM Sanctioned For Giving CME Credit For Controversial Lung Screening Paper; ACCME Demanded Corrective Action

January 9, 2009